Correlation Between GlucoTrack and Akoya Biosciences

Can any of the company-specific risk be diversified away by investing in both GlucoTrack and Akoya Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlucoTrack and Akoya Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between GlucoTrack and Akoya Biosciences, you can compare the effects of market volatilities on GlucoTrack and Akoya Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlucoTrack with a short position of Akoya Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlucoTrack and Akoya Biosciences.

Diversification Opportunities for GlucoTrack and Akoya Biosciences

0.36

Correlation Coefficient

GlucoTrack  Akoya Biosciences

Weak diversification

The 3 months correlation between GlucoTrack and Akoya is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding GlucoTrack and Akoya Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akoya Biosciences and GlucoTrack is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlucoTrack are associated (or correlated) with Akoya Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akoya Biosciences has no effect on the direction of GlucoTrack i.e., GlucoTrack and Akoya Biosciences go up and down completely randomly.

Pair Corralation between GlucoTrack and Akoya Biosciences

Given the investment horizon of 90 days GlucoTrack is expected to under-perform the Akoya Biosciences. In addition to that, GlucoTrack is 2.11 times more volatile than Akoya Biosciences. It trades about -0.2 of its total potential returns per unit of risk. Akoya Biosciences is currently generating about 0.01 per unit of volatility. If you would invest  238.00  in Akoya Biosciences on September 2, 2024 and sell it today you would lose (18.00) from holding Akoya Biosciences or give up 7.56% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

GlucoTrack  vs.  Akoya Biosciences

GlucoTrack

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days GlucoTrack has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Akoya Biosciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Akoya Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Akoya Biosciences is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with GlucoTrack and Akoya Biosciences

The main advantage of trading using opposite GlucoTrack and Akoya Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlucoTrack position performs unexpectedly, Akoya Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akoya Biosciences will offset losses from the drop in Akoya Biosciences' long position.

The idea behind GlucoTrack and Akoya Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.